With sales across all continents, Amdipharm is a truly international business. Our exponential growth has been driven by the acquisition and commercialisation of well established and trusted brands from major multinational pharmaceutical companies.
Mick Cullen, the Managing Director of our International Business has commented:
"From a standing start just a few years ago, Amdipharm will generate international sales of over $200 million in 2008. While this has been achieved without establishing a burdensome bureaucratic structure, we already have a number of enduring partnerships established with like minded companies."
The global pharmaceutical market is set to grow from $628 billion in 2006 to over $900 billion in 2012. While North America and Western Europe will remain the largest markets, more rapid growth will occur in Asia-Pacific, Latin America and Central & Eastern Europe. Amdipharm already has a presence in each of these regions and is poised for continuing global growth.
________________________
The International Business Team, led by Olivier Gire, ensures the commercialisation of Amdipharm products via business partners worldwide outside UK and Ireland.The team consists of the following experienced International Business Managers and Consultants, with responsibility over defined areas of countries, and also relies on the experience of a network of local market consultants.
ALAN WALKER - Germany, Austria, Switzerland, Africa, Middle East
Alan received a BSc degree in Chemistry from the University of Leeds, and started his career as a research chemist for Unilever. He then moved to a commercial career in the pharmaceutical industry, from Medical Representative with Zeneca Pharmaceuticals to roles of International Business Manager for several pharmaceutical companies. In over 25 years, Alan has been exposed to Europe, Latin America, Australasia, SE Asia, and Middle East.
SIMON TUCKER - Belgium, Netherlands, Latin America, Australia, New-Zealand, Canada
After graduating from London Brunel University with a BA (Hons) in International Business Studies, Simon entered the UK pharma industry by joining Pfizer. Simon has since held senior management positions in international roles across EMEA, the Far East and Australasia with Goldshield and Stiefel Laboratories, before joining Amdipharm with over 10 years international pharma experience.
GIUSEPPE GUGLIOTTA - Italy, Spain, Portugal
Giuseppe graduated in Business Administration from Catholic University Milan, and worked for a major Audit company, then for Novartis Pharma as a Licensing and Business Development manager for Italy and Southern Europe.
PAUL BURLACU - France, Scandinavia, Central and Eastern Europe, Israel, Turkey
Paul is a business management graduate and holds a masters degree in European business. Paul has over seven years of entrepreneurial international pharmaceutical business experience, managing relationships with a network of distributors, marketing and regulatory partners.
TORLEIF ROYKENES - Asia
Torleif has nearly 30 years experience in the pharmaceutical markets of Europe, Asia, Africa, and Australasia. He has earlier belonged to the management teams of MSD, Schering-Plough, Sandoz, Yamanouchi (Astellas) and ICN Pharmaceuticals (Valeant).
